Office of Research & Development |
|
Project Number: | I01CX002349-01A2 |
| Title: | A Phase II Trial to Evaluate the Effect of Itraconazole on Pathologic Complete Response Rates in Resectable Esophageal Cancer |
| Principal Investigator: | David H Wang |
| Location: | Dallas, TX |
| Congressional District Code: | 30 |
| Research Service: | Clinical Science R&D |
| Project Period: | April 2023 - March 2028 |
| Total Award Amount: | $583,004 |
| Abstract: |
View abstract and other project information on NIH RePORTER Go To NIH RePORTER |